Correction to: Josse R, Khan, A, Ngui D, Shapiro M. Denosumab, a new pharmacotherapy option for postmenopausal osteoporosis. Curr Med Res Opin 2013;29:205-16.
The authors have been made aware of an error in the key of Figure 7. Alendronate should have been distinguished from denosumab by a dotted line.
This was a formatting error and did not affect any of the study results or conclusions. The authors report the following Figure 7 which has been revised:
Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?
To request a reprint or corporate permissions for this article, please click on the relevant link below:
Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?
Obtain permissions instantly via Rightslink by clicking on the button below:
If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.